Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)
6.1900
-0.1500 (-2.37%)
Phathom Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal diseases, particularly in the area of acid-related disorders
The company is dedicated to addressing unmet medical needs through its research and development efforts, aiming to provide patients with effective treatment options. By leveraging their expertise in drug development and clinical research, Phathom seeks to bring new molecules to market that enhance patient care and improve health outcomes in the realm of digestive health.
Frequently Asked Questions
Is Phathom Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Phathom Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Phathom Pharmaceuticals, Inc. - Common Stock trade on?
Phathom Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock is PHAT on the Nasdaq Stock Market
What is the current price of Phathom Pharmaceuticals, Inc. - Common Stock?
The current price of Phathom Pharmaceuticals, Inc. - Common Stock is 6.190
When was Phathom Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Phathom Pharmaceuticals, Inc. - Common Stock was at 9:51 am EST on February 6th, 2025
What is the market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock is 269.97M
How many shares of Phathom Pharmaceuticals, Inc. - Common Stock are outstanding?
Phathom Pharmaceuticals, Inc. - Common Stock has 43.61M shares outstanding.